Diluted EPS from operations of $0.20 compare with $(0.07) in the year-ago quarter Affirms expectations for continued growth in the second quarter and full year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 05, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, […]
Sensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022
BOCA RATON, Fla, April 21, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 5, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
Joins multiple companion animals and a horse successfully treated with SRT BOCA RATON, Fla. , March 24, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that a mata mata turtle has joined the growing list of animal […]
Everything You Need to Know About the Transdermal Infusion System
In December of 2021, Sensus Healthcare announced the arrival of a new alternative to medical and aesthetic injections called TransDermal Infusion®. Approved by the FDA as a Class II biophysical alternative to infusing high weight molecule modalities into the dermis, this new system is changing the way patients receive medical and cosmetic treatments. Keep reading […]
Sensus Healthcare to Present at Two Investment Conferences in March
BOCA RATON, Fla. , March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be presenting at the following investment conferences during March: 34th Annual ROTH Conference, March 13-15 at The Ritz-Carlton, Laguna Niguel. […]
Sensus Healthcare Announces Share Repurchase Program
BOCA RATON, Fla, March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a program to purchase up to $3,000,000 of shares of its Common Stock. Commenting on this new […]
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces it has sold its Sculptura™ assets to Empyrean […]
Full Body Skin Cancer Screening Appointments
While many people enjoy spending time outdoors, not enough people truly understand how damaging the sun’s UV rays can be to the skin. Overexposure to UV rays is the number one cause of skin cancer, and as skin cancer is the most common type of cancer, it’s extremely important to know the risks and schedule […]
Report on Cellulite reduction treatments through Dermoelectroporation
Dr. Suneil Jain, N.M.D. Scottsdale Natural Medicine and Healing Clinic, LLC, 8390 E. Via de Ventura Blvd. Suite F-111 Scottsdale, AZ 85258 Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a cellulite reduction cocktail on Thighs, Abdomen, Gluteus & Knees through Dermoelectroporation®. Study Design Grades 1-2, some 3 were […]
Improvement of Facial Rhytids through a Novel Transdermal Drug Delivery System
Jaggy Rao, MD* , MD Division of Dermatology, University of Alberta Edmonton, Alberta, Canada Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal Hyaluronic Acid (HA) delivery using Dermelectroporation® Study Design 10 healthy female subjects Symmetrical periorbital rhytids Randomization: Only RIGHT or LEFT face treated Efficacy Parameters: – Photography – Histology – […]
Report on Abnormal Fat deposition treatments through Dermoelectroporation
Dr. Suneil Jain, N.M.D. Scottsdale Natural Medicine and Healing Clinic, LLC, 8390 E. Via de Ventura Blvd. Suite F-111 Scottsdale, AZ 85258 Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a fat reduction cocktail on abdomen, lateral thigh, medial thigh & back through Dermoelectroporation®. Study Design Toning, not obesity […]
Report on Treating the Crow’s feet through Dermoelectroporation
Dr. James Fulton, vivant Skin Care , Miami Florida, USA Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of Oligopeptides serum for crow’s feet treatment purposes through Dermoelectroporation®. Study Design Delivered every week for a total of 4 treatments. Oligopeptides (Vivant Skin Care) was delivered Ultrapeel® Transderm® Ionto Meso System […]
Report on Skin Biorevitalization treatment through Dermoelectroporation®
Dr. Gabriela Vasilescu, M.D. Vascular Surgery Specialist, PRIM Dept – Montedomini Clinic, via de Malcontenti, 6 – 50100, Florence, Italy Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of Specific substances for skin biorevitalization purposes through Dermoelectroporation®. Study Design 3 sessions in total. 1 sitting every two/three weeks. Specific substances […]
Report on Skin Acne reduction treatment through Dermoelectroporation®
Dr. Gabriela Vasilescu, M.D. Vascular Surgery Specialist, PRIM Dept – Montedomini Clinic, via de Malcontenti, 6 – 50100, Florence, Italy Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of Specific substances for skin acne treatment through Dermoelectroporation®. Study Design 5 sessions in total. 1 sitting every two/three weeks. Specific substances […]
Report on Hyaluronic acid cocktail treatments through Dermoelectroporation
Dr. Suneil Jain, N.M.D. Scottsdale Natural Medicine and Healing Clinic, LLC, 8390 E. Via de Ventura Blvd. Suite F-111 Scottsdale, AZ 85258 Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a Hyaluronic Acid cocktail on Perioribital & Perioral Areas through Dermoelectroporation®. Study Design Fine to medium lines of the […]
Report on smoker’s face lines treatment through Dermoelectroporation
Dr. A.Gessati*, *Aesthetic medicine Doctor, Milan, Italy. Preliminary Study Dermoelectroporation, well known and established method for transdermal substances delivery without the use of needles, promote the opening of membrane channels and allows the transdermal delivery of Hyaluronic acide based bio revitalizing and growth factor cocktails. The LED stimulation provokes , due to a controlled […]
Report on Localized Fat Deposits treatments through Dermoelectroporation
Dr. James Fulton, vivant Skin Care , Miami Florida, USA Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a cellulitic serum for localized fat deposits reduction purposes through Dermoelectroporation®. Study Design Delivered every 1 weeks for a total of 8 treatments. Cellulitic serum 5% (Vivant Skin Care) was delivered […]
Report on Treating the Crow’s feet through Dermoelectroporation
Dr. James Fulton, vivant Skin Care , Miami Florida, USA Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of Oligopeptides serum for crow’s feet treatment purposes through Dermoelectroporation®. Study Design Delivered every week for a total of 4 treatments. Oligopeptides (Vivant Skin Care) was delivered Ultrapeel® Transderm® Ionto Meso System […]
Report on Skin Aging reduction treatment through Dermoelectroporation
Dr. Gabriela Vasilescu, M.D. Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of an Hydrating cocktail for skin aging treatment through Dermoelectroporation®. Study Design 5 sessions in total. 1 sitting every three weeks. Hydrating cocktail delivered Ultrapeel® Transderm® Meso System Severe skin aging treated Materials and Methods Materials (VTF), […]
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]